Spark Ventures

Celldex Therapeutics, Inc

Biological therapies:

 

Celldex Therapeutics, Inc.

 

GlycArt AG

 

Glycoform

 

Haemostatix

 

Oxford BioMedica plc

 

Oxitec

Diagnostics & point-of-care:

 

IDG

 

Oxford Biosensors

 

Oxford Immunotec

 

Vivacta Limited

Disease Management & wellness:

 

Gemini Biomedical

 

Genosis plc

Instrumentation:

 

Teraview

IT in Healthcare:

 

Mirada Solutions

Medical Devices & Medical Technology:

 

(No investments to date)

Nanotechnology:

 

Oxonica plc

Pharmaceuticals and Speciality pharmaceuticals:

 

Allergy Therapeutics plc

 

Cyclacel Inc

 

Lectus Therapeutics

 

Medigene AG

 

Oxagen

 

PowerMed

 

Sterix

 

Vernalis plc

 

Xention

Telemedicine & e-Health:

 

(No investments to date)

 
 


Celldex Therapeutics is an integrated biopharmaceutical company that applies its comprehensive Precision Targeted Immunotherapy Platform to generate a pipeline of candidates to treat cancer and other difficult-to-treat diseases. Celldex’s immunotherapy platform includes a complementary portfolio of monoclonal antibodies, antibody-targeted vaccines and immunomodulators to create novel disease-specific drug candidates. For more information, please visit http://www.celldextherapeutics.com
© 2013 SPARK Ventures |